medigraphic.com
SPANISH

Revista Cubana de Cardiología y Cirugía Cardiovascular

ISSN 1561-2937 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 1

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2015; 21 (1)

Septal myectomy for hypertrophic cardiomyopathy with obstruction of the outflow tract of the left ventricle

Flores SA, Paredes CÁM, Marrero MRF, Rodríguez MA, Valiente MJ
Full text How to cite this article

Language: Spanish
References: 10
Page: 55-57
PDF size: 416.14 Kb.


Key words:

septal myectomy, hypertrophic cardiomyopathy.

ABSTRACT

Hypertrophic cardiomyopathy is as complications diastolic heart failure, arrhythmias, syncope and sudden death. Septal myectomy is the first indication for the treatment of this entity with obstruction of the left ventricular outflow tract (LVOT), while alcohol septal ablation is also accepted. If a patient treated with septal myectomy, as this is very rare therapeutic approach described in our country.


REFERENCES

  1. Houston BA, Stevens GR. Hypertrophic Cardiomyopathy: A Review. Clin Med Insights Cardiol 2014; 8(1): 53–65.

  2. Maron BJ, Hass TS, Goodman JS. Hypertrophic Cardiomyo-pathy: One Gene . but Many Phenotypes. Am J Cardiol 2014; 113:1772-1773.

  3. Roy RR. Hakim FA, Hurst RT, Simper D, Appleton CP. Two cases of apical ballooning syndrome masking apical hyper-trophic cardiomyopathy. Tex Heart Inst J 2014;41(2):179-83.

  4. Khalpey Z, Korovin L, Chitwood R, Poston R. Robot-assisted septal myectomy for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction. J Thorac car-diovasc Surg 2014; 147:1708-9.

  5. Roberts WC, Roberts CC, Ko JM, Grayburn PA, Tandon A, Kuiper J et al. Dramatically different phenotypic expression of hypertrophic male cousins undergoing cardiac transplanta-tion with identical disease-causing gene mutation. Am J Car-diol 2013; 111:1818-1822.

  6. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivoto I, Maron MS. Hypertrophic Cardiomyopathy. Present and fu-ture, with translation into contemporary cardiovascular medi-cine. Am J Cardiol 2014; 64(1):83-89.

  7. Panaich SS, Badheka AO, Chotani A, Mehta K, Patel NJ, Deshmukh A. Results of ventricular septal myectomy and hypertrophic cardiomiopathy (from Nationwide inpatients sample [1998-2010]). Am J Cardiol 2014; 114:1390-1395.

  8. Helder MRK, Schaff HV, Nishimura RA, Gersh BJ, Dea-rani JA, Ommen SR et al. Impact of incidental amyloidosis on the prognosis of patients with hypertrophic cardiomyopa-thy undergoing septal myectomy for left ventricular outflow tract obstruction. Am J Cardiol 2014; 114:1396-1399.

  9. Moss TJ, Krantz MJ, Zipse MM, Quaife RA, Sauer WH, Messenger JC et al. Left ventricular systolic function fol-lowing alcohol septal ablation for symptomatic hypertrophic cardiomyopathy. Am J Cardiol 2014; 113:1401-1404.

  10. Long-term consequences of the right ventricular pacing ma-nia of the 1990s for obstructive hypertrophic cardiomyopa-thy. Am J Cardiol 2014;113:191-192




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Cardiol Cir Cardiovasc. 2015;21